You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Genitourinary, 
Bladder / Urothelial
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Skin, 
Melanoma
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Genitourinary, 
Bladder / Urothelial
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Skin, 
Melanoma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Drug

Published Date: 02 Sep 2025

Revision Summary:


Drug Monograph: Added NDFP form

Sep 2025
Regimen
Published Date: 20 Aug 2025
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Premedication and Supportive Measures, Dose Modifications, and Recommended Clinical Monitoring sections, added links to T-Cell Engaging Antibody Guideline

Aug 2025
Regimen
Published Date: 20 Aug 2025
Cancer Type:
Skin, 
Melanoma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose Modifications and Recommended Clinical Monitoring sections, added links to T-Cell Engaging Antibody Guideline.

Aug 2025
Regimen
Published Date: 20 Aug 2025
Cancer Type:
Gynecologic, 
Ovary
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Pregnancy/Lactation section

Aug 2025
Regimen
Published Date: 20 Aug 2025
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Pregnancy/Lactation section

Aug 2025
Regimen
Published Date: 20 Aug 2025
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Revision Summary:

Regimen Monograph: Updated Pregnancy/Lactation section

Aug 2025

Pages